(Q37799174)

23 August 2017

title

Management of community-acquired pneumonia: a review and update (English)

1 reference

23 August 2017

0 references

Navdeep K Brar

1

1 reference

23 August 2017

Michael S Niederman

series ordinal

2

1 reference

23 August 2017

publication date

8 October 2010

1 reference

Therapeutic advances in respiratory disease

23 August 2017

published in

1 reference

23 August 2017

volume

5

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

61-78

1 reference

New evidence of risk factors for community-acquired pneumonia: a population-based study.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

CRB-65 predicts death from community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Validation of a predictive rule for the management of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Treatment costs of community-acquired pneumonia in an employed population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Development and validation of a clinical prediction rule for severe community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Validation of predictive rules and indices of severity for community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Early mortality in patients with community-acquired pneumonia: causes and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Ultrasound diagnosis of alveolar consolidation in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Quality of care, process, and outcomes in elderly patients with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Predicting bacteremia in patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

The cost of treating community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Severe community-acquired pneumonia. Risk factors and follow-up epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

High-resolution computed tomography for the diagnosis of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Antibiotic timing and errors in diagnosing pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465810381518

21 January 2018

Identifiers

DOI

10.1177/1753465810381518

1 reference

23 August 2017

1 reference